| NCT01731899 | Major Depression|Fibromyalgia | Drug: agomelatine | Universidad de Granada | | 2010-06-01 | 2014-05-06 |
| NCT01822418 | Schizophrenia|Schizophrenia-spectrum-disorders | Drug: agomelatine | Central Institute of Mental Health, Mannheim|Servier | Phase 4 | 2013-01-01 | 2013-03-27 |
| NCT01483053 | Major Depressive Disorder (MDD) | Drug: Agomelatine|Drug: Escitalopram | Baker IDI Heart and Diabetes Institute|Servier Laboratories (Australia) Pty Ltd|The Alfred|Monash Medical Centre | Phase 4 | 2014-01-01 | 2013-12-16 |
| NCT00463242 | Major Depressive Disorder | Drug: Agomelatine|Drug: paroxetine|Drug: placebo | Novartis | Phase 3 | 2007-03-01 | 2012-05-02 |
| NCT01108393 | Obsessive Compulsive Disorder | Drug: Agomelatine A|Drug: Placebo | Servier | Phase 2 | 2010-05-01 | 2014-02-12 |
| NCT01531309 | Hepatic Impairment | Drug: AGO178 | Novartis Pharmaceuticals|Servier|Novartis | Phase 1|Phase 2 | 2011-02-01 | 2013-03-06 |
| NCT01156415 | Major Depressive Disorder | Drug: AGO178|Drug: AGO178 | Novartis Pharmaceuticals|Novartis | Phase 3 | 2010-06-01 | 2013-03-06 |
| NCT01488071 | Major Depressive Disorder | Drug: Vortioxetine (Lu AA21004)|Drug: Agomelatine | H. Lundbeck A/S | Phase 3 | 2012-01-01 | 2014-02-11 |
| NCT00467402 | Major Depressive Disorder | Drug: agomelatine|Drug: placebo | Novartis | Phase 3 | 2007-04-01 | 2012-05-02 |
| NCT00411242 | Major Depressive Disorder (MDD) | Drug: agomelatine|Drug: placebo | Novartis | Phase 3 | 2006-12-01 | 2012-05-02 |
| NCT00411099 | Major Depressive Disorder | Drug: agomelatine|Drug: placebo | Novartis | Phase 3 | 2006-12-01 | 2012-05-02 |
| NCT01459250 | Renal Impairment | Drug: AGO178C | Novartis Pharmaceuticals|Novartis | Phase 1 | 2011-03-01 | 2011-10-21 |
| NCT01110902 | Major Depressive Disorder | Drug: Agomelatine (AGO178C)|Drug: Placebo | Novartis Pharmaceuticals|Novartis | Phase 3 | 2010-05-01 | 2012-09-19 |
| NCT01110889 | Major Depressive Disorder | Drug: Agomelatine (AGO178C)|Drug: Agomelatine (AGO178C)|Drug: Placebo | Novartis Pharmaceuticals|Novartis | Phase 3 | 2010-05-01 | 2013-02-21 |
| NCT00451490 | Depressive Disorder, Major | Drug: Agomelatine|Drug: Fluoxentine | National Taiwan University Hospital | | 2006-10-01 | 2007-12-24 |
| NCT02374567 | Dementia|Depression|Schizophrenia|Psychosomatic Disorders|Anxiety Disorders | Drug: Phenobarbital|Drug: Phenytoin|Drug: Carbamazepine|Drug: Oxcarbazepine|Drug: Valproic Acid|Drug: Lamotrigine|Drug: Topiramate|Drug: Gabapentin|Drug: Levetiracetam|Drug: Pregabalin|Drug: Lacosamide|Drug: Clonazepam|Drug: Biperiden|Drug: Levomepromazine|Drug: Fluphenazine|Drug: Perphenazine|Drug: Perazine|Drug: Thioridazine|Drug: Haloperidol|Drug: Melperone|Drug: Pipamperone|Drug: Bromperidol|Drug: Benperidol|Drug: Sertindole|Drug: Ziprasidone|Drug: Flupentixol|Drug: Chlorprothixene|Drug: Zuclopenthixol|Drug: Fluspirilene|Drug: Pimozide|Drug: Clozapine|Drug: Olanzapine|Drug: Quetiapine|Drug: Sulpiride|Drug: Tiapride|Drug: Amisulpride|Drug: Prothipendyl|Drug: Risperidone|Drug: Aripiprazole|Drug: Paliperidone|Drug: Diazepam|Drug: Oxazepam|Drug: Lorazepam|Drug: Bromazepam|Drug: Clobazam|Drug: Alprazolam|Drug: Hydroxyzine|Drug: Buspirone|Drug: Chloral Hydrate|Drug: Flurazepam|Drug: Nitrazepam|Drug: Triazolam|Drug: Lormetazepam|Drug: Temazepam|Drug: Midazolam|Drug: Brotizolam|Drug: Zopiclone|Drug: Zolpidem|Drug: Zaleplon|Drug: Melatonin|Drug: Clomethiazole|Drug: Diphenhydramine|Drug: Promethazine|Drug: Imipramine|Drug: Clomipramine|Drug: Opipramol|Drug: Trimipramine|Drug: Amitriptyline|Drug: Nortriptyline|Drug: Doxepin|Drug: Maprotiline|Drug: Amitriptyline oxide|Drug: Fluoxetine|Drug: Citalopram|Drug: Paroxetine|Drug: Sertraline|Drug: Fluvoxamine|Drug: Escitalopram|Drug: Tranylcypromine|Drug: Moclobemide|Drug: Mianserin|Drug: Trazodone|Drug: Mirtazapine|Drug: Bupropion|Drug: Venlafaxine|Drug: Reboxetine|Drug: Duloxetine|Drug: Agomelatine|Drug: Pyritinol|Drug: Piracetam|Drug: Donepezil|Drug: Rivastigmine|Drug: Galantamine|Drug: Memantine|Drug: Nicergoline|Drug: Acamprosate|Drug: Lithium | Hannover Medical School | Phase 3 | 2015-01-01 | 2017-02-23 |
